The Use of Generic Mobile Devices in Operating Proprietary Medical Devices – Example from a Case Report of Vagal Nerve Stimulation Therapy

Despite trialling multiple anti-epileptic medications, his seizures remain poorly controlled and was progressively worsening over the past few years. His latest regimen was a combination of sodium valproate 550 mg, clonazepam 0.5 mg twice daily, and phenytoin 260 mg. An MRI scan showed generalised cerebral atrophy and peri-ventricular heteropia without any surgically amenable lesions. Hence, his treating neurologist agreed to a trial of vagal nerve stimulation therapy. The procedure was carried out by the Austin Hospital neurosurgical team under general anaesthesia.